Prometic Cash Burn RateI'm beginning to believe that Prometic's positive announcements on progress of pipeline drugs (and most of the announcements are VERY positive) is really just a red flag to say "hey we are going to need additional funds to bring this one to market". $ either from the FDA in the form of a Priority Review Voucher or Partnership (and I don't see that happening until we hear from the FDA regarding our BLA Plasminogen submission) is the ONLY thing that will move us forward. The latest financing was at $1.70 a share and we are now below that price as I predicted. These financings put weight on the stock and quite frankly I do wonder if Prometic will be able to get another financing as their reputation must be getting tarnished. That we have to hang our hat on the the USA FDA's organization to give us an OK is somewhat sad. I understand we have to do it because of the mass exposure but I wish we could have gone the Canadian route and have the USA knocking on our door for our product. Anyway, my hope is to hear from the FDA soon, at least before we get a hostle takeover bid.